Break it Down: Control Bionics makes big Apple move with assistive tech

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, host Tylah Tully looks at Control Bionics (ASX:CBL), who is teaming up with Apple to integrate the new Brain-Computer Interface, Human Interface Device protocol across CBL’s NeuroNode and NeuroNode Trilogy products.

The integration simplifies device setup, improves neural signal quality, and enables automatic Switch Control activation for iOS devices. 

Watch the video to learn more.

While Control Bionics is a Stockhead advertiser, it did not sponsor this content.